Share on StockTwits

Prothena Co. PLC (NASDAQ:PRTA) released its earnings data on Monday. The company reported $0.06 EPS for the quarter, AnalystRatings.NET reports. The company had revenue of $15.10 million for the quarter.

Shares of Prothena Co. PLC (NASDAQ:PRTA) traded up 8.81% during mid-day trading on Monday, hitting $18.89. The stock had a trading volume of 406,901 shares. Prothena Co. PLC has a 1-year low of $15.00 and a 1-year high of $49.24. The stock has a 50-day moving average of $20.82 and a 200-day moving average of $27.. The company’s market cap is $413.8 million.

Several analysts have recently commented on the stock. Analysts at Oppenheimer initiated coverage on shares of Prothena Co. PLC in a research note on Thursday, July 10th. They set an “outperform” rating and a $40.00 price target on the stock. Analysts at Ladenburg Thalmann initiated coverage on shares of Prothena Co. PLC in a research note on Thursday, May 22nd. They set a “buy” rating and a $36.50 price target on the stock. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $41.92.

Prothena Corporation PLC is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion.

Receive News & Ratings for Prothena Co PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prothena Co PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.